Dr. David L Pollifrone , MD
Urology โข Fort Wayne, IN
11141 Parkview Plaza Dr Ste 325
Fort Wayne, IN 468451714
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 14, 2006; this date does not establish years in practice.
-
Published CMS data list 5,479 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0585 โ Injection, onabotulinumtoxina, 1 unit: 4,100 service units.
- 99214 โ Established patient outpatient office visit: 306 service units.
- 99213 โ Established patient outpatient office visit: 278 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 19 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 3,273 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl โ 919 prescription fills, including refills.
- Alfuzosin Hcl Er (Alfuzosin Hcl) โ 314 prescription fills, including refills.
- Solifenacin Succinate โ 290 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Fort Wayne, IN (2024, 23 clinicians with data). Median for this group: 546. Middle half: 241 to 1,610.
More Medicare Part B services than 80% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: 1,656. Middle half: 469 to 3,233.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 7,921 in 2020 to 5,479 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
11141 Parkview Plaza Dr Ste 325
Fort Wayne, IN 468451714
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
606 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $171,670 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $125,001 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
7,744 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$541,477 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $219.29 across 21 records.
By nature of payment
- Food and Beverage: $209.91 across 18 records.
- Education: $9.38 across 3 records.
Reporting-company totals (3 largest of 4)
- Sumitomo Pharma America, Inc.: $141.33 across 14 records.
- ABBVIE INC.: $49.72 across 3 records.
- Boston Scientific Corporation: $18.86 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Pollifrone has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Pollifrone as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Fort Wayne and Indiana
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Fort Wayne, IN (2024, 23 clinicians with data). Median for this group: 546. Middle half: 241 to 1,610.
More Medicare Part B services than 80% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: 1,656. Middle half: 469 to 3,233.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Urology in Fort Wayne, IN (2024, 23 clinicians with data). Median for this group: $54,766. Middle half: $23,843 to $167,047.
A higher Medicare-allowed amount than 65% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: $127,215. Middle half: $50,004 to $222,385.
Paid by Medicare
A higher Medicare payment amount than 75% of clinicians listed under Urology in Fort Wayne, IN (2024, 23 clinicians with data). Median for this group: $41,033. Middle half: $17,595 to $121,146.
A higher Medicare payment amount than 60% of clinicians listed under Urology in Indiana (2024, 207 clinicians with data). Median for this group: $90,868. Middle half: $37,737 to $162,559.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Urology in Fort Wayne, IN (2024, 25 clinicians with data). Median for this group: 578. Middle half: 308 to 2,953.
More Part D prescriptions than 90% of clinicians listed under Urology in Indiana (2024, 230 clinicians with data). Median for this group: 1,184. Middle half: 363 to 2,109.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Fort Wayne, IN (2024, 25 clinicians with data). Median for this group: $101,918. Middle half: $25,202 to $270,277.
A higher Part D drug cost than 90% of clinicians listed under Urology in Indiana (2024, 230 clinicians with data). Median for this group: $103,427. Middle half: $22,478 to $269,302.
34 active clinicians are listed under Urology with a practice address in Fort Wayne, IN (308 in Indiana).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Fort Wayne
29.4% of these 34 clinicians have the CMS telehealth indicator.
70.6% of these 34 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 31% from 7,921 in 2020 to 5,479 in 2024.
- 2020: 7,921
- 2021: 6,994
- 2022: 5,970
- 2023: 5,263
- 2024: 5,479
-
Medicare-allowed amount
Medicare-allowed amount decreased 14% from $199,660 in 2020 to $171,670 in 2024.
- 2020: $199,660
- 2021: $199,336
- 2022: $164,073
- 2023: $187,367
- 2024: $171,670
-
Paid by Medicare
Paid by Medicare decreased 17% from $151,130 in 2020 to $125,001 in 2024.
- 2020: $151,130
- 2021: $148,021
- 2022: $121,549
- 2023: $138,126
- 2024: $125,001
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 32% from 2,477 in 2020 to 3,273 in 2024.
- 2020: 2,477
- 2021: 2,400
- 2022: 2,530
- 2023: 2,896
- 2024: 3,273
-
30-day fills
30-day fills increased 53% from 5,051 in 2020 to 7,744 in 2024.
- 2020: 5,051
- 2021: 5,395
- 2022: 5,615
- 2023: 6,491
- 2024: 7,744
-
Part D drug cost
Part D drug cost varied from year to year: $579,040 in 2020 and $541,477 in 2024.
- 2020: $579,040
- 2021: $420,391
- 2022: $460,845
- 2023: $520,710
- 2024: $541,477
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $592.25 in 2021 to $219.29 in 2025.
- 2021: $592.25
- 2022: $412.92
- 2023: $1,099.29
- 2024: $682.28
- 2025: $219.29
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 21 records totaling $219.29.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $33.61 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.04 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $21.64 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
General - Erectile Dysfunction | General | $18.86 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $14.40 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $13.68 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $13.68 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $13.50 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $10.06 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $8.99 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $8.61 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $8.11 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $7.75 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $7.67 |
| Travere Therapeutics, Inc. |
Education
In-kind items and services
|
Thiola | General | $3.82 |
| Travere Therapeutics, Inc. |
Education
In-kind items and services
|
Thiola | General | $3.01 |
| Travere Therapeutics, Inc. |
Education
In-kind items and services
|
Thiola | General | $2.55 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $1.44 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $0.72 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $0.59 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $0.56 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0585
Injection, onabotulinumtoxina, 1 unit
|
4,100 | 25 | $14.76 | $6.26 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
306 | 262 | $196.00 | $119.40 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
278 | 254 | $135.00 | $84.46 |
|
81003
Automated urinalysis test
|
213 | 112 | $21.00 | $2.20 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
153 | 22 | $4327.08 | $178.18 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
72 | 23 | $5.43 | $2.45 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
65 | 50 | $640.00 | $219.30 |
|
52287
Exam with injections of chemical for destruction of bladder using an endoscope
|
41 | 25 | $1026.00 | $354.31 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
34 | 34 | $308.00 | $155.27 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
33 | 28 | $111.00 | $10.15 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
30 | 29 | $94.00 | $22.86 |
|
76872
Ultrasound scan of pelvic region through rectum
|
27 | 26 | $458.00 | $123.31 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
26 | 18 | $108.00 | $32.19 |
|
52332
Insertion of stent in ureter using an endoscope
|
21 | 19 | $1621.00 | $117.77 |
|
55700
Biopsy of prostate gland
|
19 | 18 | $595.00 | $212.28 |
|
50590
Shock wave crushing of kidney stones
|
18 | 18 | $3361.00 | $527.86 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
17 | 17 | $257.00 | $120.59 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
14 | 14 | $90.00 | $52.50 |
|
81002
Urinalysis, manual test
|
12 | 12 | $22.00 | $3.41 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 919 | 78,738 | $9,798.60 | 302 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 314 | 27,093 | $6,383.20 | 94 |
| Solifenacin Succinate | Solifenacin Succinate | 290 | 21,707 | $14,234.03 | 100 |
| Finasteride | Finasteride | 283 | 24,963 | $3,192.25 | 89 |
| Dutasteride | Dutasteride | 192 | 17,252 | $6,391.64 | 60 |
| Cephalexin | Cephalexin | 189 | 1,462 | $970.64 | 128 |
| Gemtesa | Vibegron | 154 | 9,706 | $156,657.92 | 47 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 131 | 853 | $1,555.44 | 67 |
| Myrbetriq | Mirabegron | 130 | 9,302 | $141,014.39 | 37 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 121 | 515 | $368.22 | 82 |
| Testosterone Cypionate | Testosterone Cypionate | 80 | 3,600 | $4,159.22 | 29 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 66 | 591 | $294.70 | 54 |
| Levofloxacin | Levofloxacin | 58 | 459 | $214.00 | 48 |
| Estradiol | Estradiol | 36 | 2,585 | $2,688.10 | 20 |
| Bicalutamide | Bicalutamide | 34 | 2,280 | $1,234.69 | โ |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 158 | $153.86 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | 2,290 | $253.66 | โ |
| Testosterone | Testosterone | 21 | 1,800 | $3,978.11 | 11 |
| Potassium Citrate Er | Potassium Citrate | 20 | 1,658 | $2,277.86 | โ |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 19 | 35 | $37.48 | 18 |
| Allopurinol | Allopurinol | 19 | 1,590 | $53.63 | โ |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | 1,002 | $256.40 | โ |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | 1,530 | $703.43 | โ |
| Fluconazole | Fluconazole | 16 | 75 | $65.80 | โ |
| Terazosin Hcl | Terazosin Hcl | 16 | 1,416 | $156.94 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-04-03NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20031217000212
IN
2668378290
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Nurse Practitioner
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 11141 PARKVIEW PLAZA DR STE 325, FORT WAYNE, IN 468451714 (Tel: 2604255400)
Registered at 11109 PARKVIEW PLAZA DR # 117, FORT WAYNE, IN 468451701
Registered at 3702 NEW VISION DR, BLDG B, FORT WAYNE, IN 468451703 (Tel: 2602668210)
NPI status registered as active in NPPES database
Registered at 2512 E DUPONT RD, SUITE 100, FORT WAYNE, IN 468251675 (Tel: 2694366667)
Registered at 10351 DAWSONS CREEK BLVD, STE. D, FORT WAYNE, IN 468251904 (Tel: 2609691950)
Recorded as DAVID POLLIFRONE, MD
Urology (license number reported to NPPES: IN 01046999A)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Fort Wayne
- Dr. Colin Linke, DO
- Dr. Scott Palmer, MD
- Dr. Jorge Arzola, MD
- Dr. Satish Velagapudi, MD
- Dr. Pranav Panchatsharam, DO
- Dr. Adam Thomas, MD
Mailing Address
11109 Parkview Plaza Dr # 117
Fort Wayne, IN 468451701